Bridging Guidelines and Practice: Expert Insights on Early Rosuvastatin–Ezetimibe Combination Therapy

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Sunil Sathe , Aniruddha B. Chandorkar , Mukesh Rao , Sunil Lhila , Dhiraj Kumar , Bappaditya Kumar , Basabendra Choudhury , Rohit Kumar , Lawrence Jesuraj , J. Kannan , Bhagayshree Mohod , Mayur Mayabhate , Akhilesh Sharma
DOI: 10.5281/zenodo.18873237
Cited by: 0

Abstract

Background: Cardiovascular disease remains the leading cause of mortality globally and in India, driven by a high burden of dyslipidemia and premature coronary artery disease. Despite widespread statin use, attainment of recommended LDL-C targets in real-world practice remains suboptimal. Contemporary ESC/EAS, CSI, and LAI guidelines advocate aggressive LDL-C goals (

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Cancer Lipids and Metabolism Blood Pressure and Hypertension Studies

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
17 February 2026
Language
EN